Xilio Therapeutics (XLO) Market Capitalization (2021 - 2026)

Xilio Therapeutics has disclosed Market Capitalization across 6 years of filings, most recently posting $185.9 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 183.48% year-over-year to $185.9 million; the TTM figure through Jun 2026 stood at $185.9 million (up 183.48% YoY), while the FY2025 annual figure was $74.9 million, up 71.46% from the prior year.
• Market Capitalization came in at $185.9 million for Q2 2026 at Xilio Therapeutics, up from $137.5 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $193.6 million in Q1 2022 to a low of $15.2 million in Q4 2023.
• Average Market Capitalization over 5 years is $82.1 million, with a median of $72.9 million recorded in 2022.
• Year-over-year, Market Capitalization plunged 79.42% in 2023 and surged 187.78% in 2024.
• Over 5 years, Market Capitalization stood at $73.8 million in 2022, then sank by 79.42% to $15.2 million in 2023, then surged by 187.78% to $43.7 million in 2024, then surged by 71.46% to $74.9 million in 2025, then soared by 148.12% to $185.9 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $185.9 million in Q2 2026, $137.5 million in Q1 2026, and $74.9 million in Q4 2025.